Martine Rothblatt's SEC Filing on Common Stock Sales

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice with the SEC regarding the sale of common stock. The filing details the sale of 4,000 shares on October 22, 2025, with an aggregate market value of $1,688,607.20. Additionally, the filing includes information on multiple sales of common stock over the past three months, totaling significant gross proceeds. The securities were acquired through executive deferred compensation and were sold via TD Securities (USA) LLC on the NASDAQ exchange. The filing also notes that there are 45,230,000 common shares outstanding.